00:01
Let's move to our next case.
00:04
A 59-year-old man is seen in clinic for indigestion,
nausea and the yellowing of his eyes for the past six months.
00:11
He has three to four voluminous stools per day.
00:15
His stools are clay colored and urine is dark.
00:19
He lost 9 kg unintentionally in the last six months.
00:23
His medical history is significant for a 50 pack-year smoking history and prediabetes.
00:29
Vitals are normal. BMI is 21.
00:32
Exam is notable for temporal wasting, scleral icterus and epigastric tenderness
without rebound or guarding.
00:39
His labs reveal a total bilirubin of 2.8 and an elevated CA 19-9.
00:45
So we're asked, what is the best initial imaging test for diagnosis?
So we can point out here that he has obstructive jaundice with weight loss and indigestion,
and a smoker with prediabetes.
00:59
So at this point, we should be thinking about different types of cancer.
01:03
In addition, he has cachexia and jaundice on exam.
01:08
And his elevated total bilirubin shows that he has cholestasis.
01:14
This elevated CA 19-9 is neither a sensitive nor specific finding, but we'll discuss that later.
01:23
That brings us to pancreatic adenocarcinoma.
01:27
Pancreatic adenocarcinoma can present with jaundice.
01:30
From the jaundice, patients may describe dark urine and light-colored stools.
01:34
They may have nausea, pain after eating, unintended weight loss.
01:39
And they may have upper abdominal pain as well as back pain.
01:44
On physical exam, they often appear cachectic. They may have muscle wasting.
01:50
They're often jaundiced and there are several particular eponyms
that you should know in relation to pancreatic cancer.
01:57
One of them is Virchow's node.
01:59
This is when a patient has a palpable, supraclavicular lymphadenopathy.
02:05
The second eponym you should know is Courvoisier's sign.
02:09
This is a when you can actually palpate a gallbladder.
02:13
And this is from distal bile duct compression leading to a palpable a gallbladder.
02:18
The last eponym is Trousseau's syndrome.
02:21
This is when patients with pancreatic cancer can develop migratory thrombophlebitis.
02:26
Unfortunately with pancreatic cancers, the prognosis is very poor.
02:32
A five-year survival rate is only about 5%.
02:35
And this is because patients often present with very vague symptoms
and at the time of diagnosis, often have very late stage disease.
02:43
So, what are the risk factors for pancreatic cancer?
Advanced age, so greater than 50 years.
02:50
A family history of pancreatic cancer, cigarette smoking, obesity and diabetes
and rarely, introductal papillary mucinous neoplasms
which are premalignant lesions that can occur in the pancreas.
03:05
So the diagnosis is primarily done with imaging.
03:08
A CT of the abdomen has a very good sensitivity, around 90% for detecting pancreatic cancer.
03:15
Shown here is a CT of the abdomen during the pancreatic phase of contrast
showing an isodense adenocarcinoma in the head of the pancreas.
03:25
You may also do an endoscopic ultrasound for small tumors that you cannot detect on CT scan.
03:31
And with this procedure, you can also do what's called an FNA
or a Fine Needle Aspiration to obtain results for a biopsy.
03:39
When the diagnosis is equivocal, you may also do MRCP or ERCP to help you confirm the diagnosis.
03:47
Some lab studies may be helpful in the diagnosis of this disease.
03:53
You want to check a liver panel to evaluate for cholestasis.
03:57
A serum lipase may be helpful to make sure that the patient
does not also have pancreatitis from obstruction of the pancreatic duct.
04:05
And as we mentioned, there is the CA 19-9 tumor marker.
04:09
Keep in mind this has poor sensitivity and specificity for this diagnosis.
04:14
But checking it may be useful for prognosis and for monitoring patients' response to treatment.
04:21
So, the staging of pancreatic adenocarcinoma depends on tumor, nodal and metastasis staging.
04:29
In general, stage I disease is resectable.
04:34
This is when it's confined within the pancreas.
04:37
Stage II disease may be borderline resectable.
04:41
In these cases, they may have local spread just outside the pancreas to adjacent lymph nodes.
04:47
Once you reach stage III, this is when you have had spread to multiple lymph nodes
or major blood vessels near the pancreas.
04:55
This has now become unresectable disease. And lastly stage IV, is metastatic cancer.
05:02
When you have now spread of the cancer to distant organs, this is not resectable.
05:06
So, as far as treatment goes, surgical resection is the only curative therapy.
05:12
But as we spoke about earlier, very limited stages of pancreatic cancer
can be treated with this type of surgery.
05:19
Here on the right is one of the procedures
that is done for pancreatic cancer called a Whipple procedure or a pancreaticoduodenectomy.
05:28
This is when you remove the head of the pancreas.
05:31
And then the remaining pancreas, bile duct, and stomach are then attached to the small intestine.
05:37
For unresectable disease, the main stay of treatment
involves chemotherapy plus or minus radiation.
05:46
This tends to be with gemcitabine-based regimens.
05:49
We do have newer regimens using five fluorouracil.
05:52
And there are always evolving therapies with immunotherapy for this cancer.
05:58
So now let's return to our case.
06:02
A 59-year-old man, now with obstructive jaundice, weight loss and indigestion.
06:07
We know he's a smoker and has prediabetes
both of which are risk factors for these type of cancer.
06:12
He is cachectic. He has cholestasis on his labs.
06:16
And although we said that CA 19-9 is not sensitive nor specific,
all of the clinical features combined with his findings support a diagnosis of pancreatic cancer.
06:27
So the best initial imaging test for diagnosis would be a CT of the abdomen
which has 90% sensitivity and can help us with staging information for this disease.
06:39
Thank you very much for your attention.